Establishment of highly sensitive analytical method for chondroitin sulfate by flow injection chemiluminescence

Ultra-sensitive detection of 5-fluorouracil by flow injection chemiluminescence immunoassay based on Fenton-like effect of single atom Co nanozyme

Single atom nanozymes (SAzymes) are considered as the most hopeful candidates for replacing natural enzymes. In this work, a flow-injection chemiluminescent immunoassay (FI-CLIA) based on a Fenton-like activity single atom cobalt nanozyme (Co SAzyme) was developed for the rapid and sensitive detection of 5-fluorouracil (5-Fu) in serum for the first time. Co SAzyme was prepared by an in-situ etching method at room temperature using ZIF-8 metal-organic frameworks (ZIF-8 MOFs). With excellent chemical stability and ultra-high porosity of ZIF-8 MOFs as the core, Co SAzyme presents high Fenton-like activity which can catalyze the decomposition of H₂O₂ to produce large amounts of superoxide radical anions, thus effectively amplifying the chemiluminescence of the Luminol-H₂O₂ system. In addition, carboxyl-modified resin beads were used as the substrate to load more antigens due to its advantages of good biocompatibility and large specific surface area. Under optimal conditions, the detection range of 5-Fu was 0.001-1000 ng mL^-1 with a limit of detection of 0.29 pg mL^-1 (S/N = 3). Furthermore, the immunosensor was successfully applied for the detection of 5-Fu in human serum samples with satisfactory results, displaying the potential application of this strategy for bioanalysis and clinical diagnosis.

Enhanced electrochemiluminescence of luminol based on Cu2O-Au heterostructure enabled multiple-amplification strategy

Herein, a credible construction strategy to improve electrochemiluminescence (ECL) of luminol was developed based on Cu₂O-Au heterostructures. Summarily, gold nanoparticles (AuNPs) were anchored on surface of Cu₂O nanocube (Cu₂O@AuNPs) by spontaneous reduction reaction. Then, luminol molecules were concentrated on Cu₂O@AuNPs using L-Cysteine (Cys) as covalent linkage to build the composite emitter (Cu₂O@AuNPs-Cys-luminol). The enhancement mechanism was realized by following aspects: (I) Cu₂O@AuNPs worked as electrocatalyst for glucose to generate coreactant of H₂O₂ in situ, avoiding the instability of direct addition of H₂O₂. (II) luminol molecules were firmly attached on Cu₂O@AuNPs to achieve centralized and strong luminescence at low consumption. (III) Cys acted as an intramolecular coreactant and directly linked to luminol to increase luminous efficiency. To validate the effectiveness, a sandwiched immunoassay was built using concanavalinA (ConA) as analyte. Electroreduced graphene film as substrate provided phenoxy-derivatized dextran (DexP) with abundant binding sites and improved conductivity. To improve the specificity, DexP was used to identify ConA via the specific carbohydrate-ConA interaction. Then, Cu₂O@AuNPs-Cys-luminol was modified on electrode as ECL signal indicator. The ECL immunosensor achieved determination of ConA with low detection limit of 2.9 × 10^-5 ng/mL and excellent stability of continuous potential scan for 8 cycles. Experimental results demonstrated that the proposed construction strategy made considerable progress in ECL efficiency and stability of luminol. The creational pattern of construction strategy achieves high detection capabilities to ConA and expands the applicability of luminol in ECL system. It is expected to have more potential application value in immunoassay with universality.